Incensus Pharma IvS: Financial statements 2020
CVR: 37162949
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Incensus Pharma IvS (CVR 37162949) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.
- Gross Profit
- DKK -1,500
- Profit/Loss
- DKK -1,500
- Equity
- DKK -7,244
- Total Assets
- DKK 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -2 t. | -2 t. | -7 t. | - |
| 2019 | - | -1 t. | -2 t. | -6 t. | - |
| 2018 | - | -1 t. | -1 t. | -4 t. | - |
| 2017 | - | -1 t. | -1 t. | -3 t. | - |
Official annual report
How creditworthy is Incensus Pharma IvS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Incensus Pharma IvS has published its annual report for 2019. Gross profit came to DKK -1,484, and the net result was DKK -1,625.
About Incensus Pharma IvS
Incensus Pharma IvS was a Danish company of the type Iværksætterselskab based in Hinnerup, founded in 2015. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.